Published in Neuropsychiatr Dis Treat on March 25, 2015
Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry (1995) 5.59
Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev (2008) 4.43
Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol (2002) 2.88
The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry (1998) 2.39
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A (2004) 2.36
The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. J Psychopharmacol (2008) 1.32
Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet (2003) 1.29
Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev (2000) 1.29
A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res (2005) 1.17
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res (2005) 1.03
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
The genomics of schizophrenia: update and implications. J Clin Invest (2013) 0.98
No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry (2005) 0.90
No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr Res (2006) 0.87
Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population. Am J Med Genet B Neuropsychiatr Genet (2008) 0.85
Association of GRM3 polymorphism with white matter integrity in schizophrenia. Schizophr Res (2014) 0.85
Alcohol dependence and hospitalization in schizophrenia. Schizophr Res (1999) 0.84
The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. Neurosci Lett (2014) 0.84
DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology (2009) 0.84
Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet (2007) 0.82
Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia. Psychopharmacology (Berl) (2014) 0.81
Association of single-nucleotide polymorphisms in a metabotropic glutamate receptor GRM3 gene subunit to alcohol-dependent male subjects. Alcohol Alcohol (2014) 0.80
Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis. Neuropsychiatr Dis Treat (2014) 0.80
Metabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese population. PLoS One (2014) 0.78
Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia. Psychiatry Clin Neurosci (2008) 0.77